Displaying 1 to 20 of 36 investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
Aileron Therapeutics Inc Developing a breakthrough proprietary peptide technology platform |
United States | N/A Active |
||
|
|
Anthera Pharmaceuticals Inc |
United States | N/A Active |
||
|
|
Avid Radiopharmaceuticals Inc |
United States | 1 May 2009 | Series D Active |
|
|
|
Avid Radiopharmaceuticals Inc |
United States | 1 Jan 2006 | Series A Active |
|
|
|
Avid Radiopharmaceuticals Inc |
United States | 1 May 2007 | Series C Active |
|
|
|
Bayhill Therapeutics A biopharmaceutical company focused on the translation of research into therapeutics for the treatment of autoimmune diseases. |
United States | N/A |
||
|
|
Cabrellis Pharmaceuticals Corp Development of important therapies for the treatment of cancer |
United States | 7 Aug 2006 | Series A |
|
|
|
Cerulean Pharma Inc |
United States | 1 Dec 2011 | Series D |
|
|
|
Cerulean Pharma Inc |
United States | 1 Nov 2010 | Series C |
|
|
|
CGI Pharmaceuticals Inc A biopharmaceutical company developing small molecule therapeutics for multiple oncology and immunology-based indications. |
United States | N/A |
||
|
|
Conforma Therapeutics Corp Novel drugs company for the selective treatment of cancer. |
United States | N/A |
||
|
|
Cylene Pharmaceuticals Inc Clinical stage private company developing small molecule drugs against newly validated cancer targets. |
United States | 1 Jan 2007 | Series C Active |
|
|
|
Cylene Pharmaceuticals Inc Clinical stage private company developing small molecule drugs against newly validated cancer targets. |
United States | 1 Sep 2010 | Series D Active |
|
|
Fluidigm Corp Developer and manufacturer of microfluidic systems for markets in the life science and agricultural biotechnology industries. |
United States | 1 Jan 2007 | Series E Active |
|
|
|
Forma Therapeutics Inc |
United States | N/A |
||
|
|
GlobeImmune Inc Biopharmaceuticals company. |
United States | N/A |
||
|
|
Hemaquest Pharmaceuticals Inc |
United States | 1 Nov 2007 | Series A Active |
|
|
|
Hemaquest Pharmaceuticals Inc |
United States | 1 Mar 2012 | Series B Active |
|
|
|
Hemaquest Pharmaceuticals Inc |
United States | 1 Apr 2010 | Series B Active |
|
|
|
Hydra Biosciences Inc |
United States | N/A |